These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9074839)

  • 1. Choosing the right macrolide antibiotic. A guide to selection.
    Charles L; Segreti J
    Drugs; 1997 Mar; 53(3):349-57. PubMed ID: 9074839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of macrolide use in pediatrics.
    Klein JO
    Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of macrolides and ketolides: focus on respiratory tract infections.
    Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
    Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Whitman MS; Tunkel AR
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide antibiotics in paediatric infectious diseases.
    Guay DR
    Drugs; 1996 Apr; 51(4):515-36. PubMed ID: 8706592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin).
    Kaplan EL; Gooch III WM; Notario GF; Craft JC
    Clin Infect Dis; 2001 Jun; 32(12):1798-802. PubMed ID: 11360224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
    Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
    HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-benefit assessment of therapies for Mycobacterium avium complex infections.
    Griffith DE
    Drug Saf; 1999 Aug; 21(2):137-52. PubMed ID: 10456381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prophylaxis of Mycobacterium avium complex.
    Young LS
    Int J STD AIDS; 1996; 7 Suppl 1():23-7. PubMed ID: 8652724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
    Shimizu T; Suzaki H
    Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Peters DH; Clissold SP
    Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections.
    Amsden GW; Peloquin CA; Berning SE
    Drugs; 1997 Jul; 54(1):69-80. PubMed ID: 9211081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.
    Dunn CJ; Barradell LB
    Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.